Lymphoma News TodayStem Cell Transplants Bring Long-term Benefits to Relapsed Follicular Lymphoma PatientsLymphoma News TodayThe study included 1,567 patients with relapsed follicular lymphoma who underwent stem cell transplant from a human leukocyte a… Continue reading
Genetic Engineering & Biotechnology NewsNanospears May Revolutionize Gene TherapyGenetic Engineering & Biotechnology NewsCurrent gene therapy approaches rely on modified viruses, external electrical fields, or chemicals to penetrate cell membranes and … Continue reading
Rare Pediatric Disease Designation Granted to Infantile Batten Disease Gene TherapyRare Disease ReportThis morning, Abeona Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to ABO-… Continue reading
Xconomy |
Xconomy: Arcus Bio Pulls Off IPO, Raises $120M for Cancer …
Xconomy Arcus Biosciences has raised $120 million from an initial public offering as the cancer immunotherapy developer looks ahead to reporting its first clinical. Cancer-fighting Arcus (NYSE: RCUS), backed by Alphabet’s GV …San Francisco Business Times |
The Advertiser |
“Off-The-Shelf” Third Party T Cells for CAR-T Therapy Under Investigation
Cancer Network A matched donor with similar immunity is not required and neither are the patient’s own T cells. “We were able to efficiently (> 90%) delete both copies of CD7 and the T-cell receptor alpha subunit (TRAC) and insert a unique CAR to CD7 in human T cells … Adelaide’s Carina Biotech makes killer cells to cure cancerThe Advertiser |